Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.28 +0.84 (+15.34%)
At close: Nov 11, 2026 · 4:00 PM EST

Phathom Pharmaceuticals (PHAT) Asset Writedowns and Impairment (2024 - 2026)

Updated

Analysis

Phathom Pharmaceuticals (PHAT) Asset Writedowns and Impairment (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Phathom Pharmaceuticals 442.66 Mn -246.70 Mn 66.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 917,000.00
Dec 31, 2025 -539,000.00
Jun 30, 2025 -80,000.00
Mar 31, 2025 899,000.00
Dec 31, 2024 120,000.00
Sep 30, 2024 473,000.00
Jun 30, 2024 243,000.00
API Access

Phathom Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=PHAT&period=max&api_key=YOUR_API_KEY